Specialty
Intensive Care Medicine
Pediatrics & Neonatology
Occupational Medicine
Emergency Medicine
Anesthesiology
Pulmonology
Internal Medicine
Radiology
Nephrology
Allergy and Immunology
Sports Medicine
Nutrition
Neurosurgery
Cardiovascular medicine
Surgery
Gynecology
Companies
Departments
Cardiac Rehabilitation
Imaging Department
OB/GYN Department
Dialysis Department
Vpk: Peak Velocity of flow
Vti: Velocity Time Integral
HR: Heart Rate
MD: Minute Distance
ET%: Ejection Time Percent
SV: Stroke Volume
SVI: Stroke Volume Index
SVV: Stroke Volume Variability
CO: Cardiac Output
CI: Cardiac Index
SVR: Systemic Vascular Resistance
SVRI: Systemic Vascular Resistance Index
Pmn: Mean Pressure Gradient
FT: Flow Time
FTc: Flow Time Corrected
SW: Stroke Work
CPO: Cardiac Power
SMII: Inotropy Index
PKR: Potential Kinetic Ratio
Hemodynamic Monitoring
USCOM 1A is a non-invasive, transcutaneous Doppler ultrasound device designed to simplify acquisition and storage of high-fidelity measurement and trending information of cardiovascular performance. It uses state-of-the art electronics, high fidelity ultrasonics and advanced signal processing to deliver accurate and simple measurements of Cardiac Output. Advanced trend analysis and reporting are provided using the proprietary Uscom Reporter software. The USCOM 1A monitor provides an intuitive touch screen user interface allowing for instant access to both live and recorded information. The USCOM 1A monitor can store tens-of-thousands of patient files and weighs just 6 kilograms. The USCOM 1A is available with its own custom roll stand, making it highly portable and ideal for transfer from patient-to-patient or ward-to-ward.
Uscom has a mission to demonstrate leadership in science and create non-invasive devices that guide clinicians to improved clinical care and patient outcomes. Uscom is an emerging global leader in non-invasive cardiovascular and pulmonary medical devices, developing innovative technologies to solve the challenges of global disease and health care.
Uscom is driven by a commercial ambition to lead global health innovations and grow shareholder wealth.
The company was founded in 2000 on translational cardiovascular research by Associate Professor Rob Phillips at the University of Queensland. The USCOM 1A was the original device developed and taken to market in 2006, and continues as the cornerstone product of the company. Uscom has sold over 1000 1A units into leading hospitals and clinics worldwide.
Uscom has an aggressive global growth strategy Uscom which has resulted in the acquisition of practice changing and complimentary non-invasive cardiovascular and pulmonary technologies. Uscom acquired Pulsecor Limited in 2013, and Thor Laboratories in 2015.
Uscom are the experts in circulation delivering innovative, practice changing non-invasive cardiovascular and pulmonary monitoring devices. Uscom markets the USCOM 1A advanced hemodynamic monitor, the BP+ and BP+ Reporter, and SpiroSonic digital ultrasonic spirometer series and the proprietary SpiroReporter software. These devices are changing the way cardiovascular and pulmonary medicine is practiced.
Uscom has abundant IP and a strong product pipeline projecting well into the next 10 years. We are looking forward to working with our current key opinion leaders and those that join us to deliver the clinical innovations we are currently working on to patients worldwide. Clinical benefit is the foundation of the value of Uscom and we pride ourselves in creating devices which genuinely contribute to improved care.
For Uscom it is an exciting time as our clinical and commercial value is increasingly being recognised worldwide.
We are proud of the achievements we have delivered to health care over the last 10 years, and we are looking forward to the innovations which we are continuing to develop for delivery over the next 10 years. For Uscom medical innovation is our business, and it is an extremely exciting time and the opportunities are great.